Cargando…

Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors

Human insulin-like growth factor I (hIGF-I) is a kind of growth factor with clinical significance in medicine. Up to now, E. coli expression system has been widely used as a host to produce rhIGF-1 with high yields. Batch cultures as non-continuous fermentations were carried out to overproduce rhIGF-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjbari, Javad, Babaeipour, Valiollah, Vahidi, Hossein, Moghimi, Hamidreza, Mofid, Mohammad Reza, Namvaran, Mohammad Mehdi, Jafari, Sevda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518120/
https://www.ncbi.nlm.nih.gov/pubmed/26330880
_version_ 1782383286088105984
author Ranjbari, Javad
Babaeipour, Valiollah
Vahidi, Hossein
Moghimi, Hamidreza
Mofid, Mohammad Reza
Namvaran, Mohammad Mehdi
Jafari, Sevda
author_facet Ranjbari, Javad
Babaeipour, Valiollah
Vahidi, Hossein
Moghimi, Hamidreza
Mofid, Mohammad Reza
Namvaran, Mohammad Mehdi
Jafari, Sevda
author_sort Ranjbari, Javad
collection PubMed
description Human insulin-like growth factor I (hIGF-I) is a kind of growth factor with clinical significance in medicine. Up to now, E. coli expression system has been widely used as a host to produce rhIGF-1 with high yields. Batch cultures as non-continuous fermentations were carried out to overproduce rhIGF-I in E. coli. The major objective of this study is over- production of recombinant human insulin-like growth factor I (rhIGF-I) through a developed process by recruiting effective factors in order to achieve the most recombinant protein. In this study we investigated the effect of culture medium, induction temperature and amount of inducer on cell growth and IGF-1 production. Taguchi design of experiments (DOE) method was used as the statistical method. Analysis of experimental data showed that maximum production of rhIGF-I was occurred in 32y culture medium at 32 °C and 0.05 Mm IPTG. Under this condition, 0.694 g/L of rhIGF-I was produced as the inclusion bodies. Following optimization of these three factors, we have also optimized the amount of glucose and induction time in 5 liter top bench bioreactor. Full factorial design of experiment method was used for these two factors as the statistical method. 10 g/L and OD(600)=5 were selected as the optimum point of Glucose amount and induction time, respectively. Finally, we reached to a concentration of 1.26 g/L rhIGF-1 at optimum condition.
format Online
Article
Text
id pubmed-4518120
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-45181202015-09-01 Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors Ranjbari, Javad Babaeipour, Valiollah Vahidi, Hossein Moghimi, Hamidreza Mofid, Mohammad Reza Namvaran, Mohammad Mehdi Jafari, Sevda Iran J Pharm Res Original Article Human insulin-like growth factor I (hIGF-I) is a kind of growth factor with clinical significance in medicine. Up to now, E. coli expression system has been widely used as a host to produce rhIGF-1 with high yields. Batch cultures as non-continuous fermentations were carried out to overproduce rhIGF-I in E. coli. The major objective of this study is over- production of recombinant human insulin-like growth factor I (rhIGF-I) through a developed process by recruiting effective factors in order to achieve the most recombinant protein. In this study we investigated the effect of culture medium, induction temperature and amount of inducer on cell growth and IGF-1 production. Taguchi design of experiments (DOE) method was used as the statistical method. Analysis of experimental data showed that maximum production of rhIGF-I was occurred in 32y culture medium at 32 °C and 0.05 Mm IPTG. Under this condition, 0.694 g/L of rhIGF-I was produced as the inclusion bodies. Following optimization of these three factors, we have also optimized the amount of glucose and induction time in 5 liter top bench bioreactor. Full factorial design of experiment method was used for these two factors as the statistical method. 10 g/L and OD(600)=5 were selected as the optimum point of Glucose amount and induction time, respectively. Finally, we reached to a concentration of 1.26 g/L rhIGF-1 at optimum condition. Shaheed Beheshti University of Medical Sciences 2015 /pmc/articles/PMC4518120/ /pubmed/26330880 Text en © 2015 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ranjbari, Javad
Babaeipour, Valiollah
Vahidi, Hossein
Moghimi, Hamidreza
Mofid, Mohammad Reza
Namvaran, Mohammad Mehdi
Jafari, Sevda
Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors
title Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors
title_full Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors
title_fullStr Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors
title_full_unstemmed Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors
title_short Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors
title_sort enhanced production of insulin-like growth factor i protein in escherichia coli by optimization of five key factors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518120/
https://www.ncbi.nlm.nih.gov/pubmed/26330880
work_keys_str_mv AT ranjbarijavad enhancedproductionofinsulinlikegrowthfactoriproteininescherichiacolibyoptimizationoffivekeyfactors
AT babaeipourvaliollah enhancedproductionofinsulinlikegrowthfactoriproteininescherichiacolibyoptimizationoffivekeyfactors
AT vahidihossein enhancedproductionofinsulinlikegrowthfactoriproteininescherichiacolibyoptimizationoffivekeyfactors
AT moghimihamidreza enhancedproductionofinsulinlikegrowthfactoriproteininescherichiacolibyoptimizationoffivekeyfactors
AT mofidmohammadreza enhancedproductionofinsulinlikegrowthfactoriproteininescherichiacolibyoptimizationoffivekeyfactors
AT namvaranmohammadmehdi enhancedproductionofinsulinlikegrowthfactoriproteininescherichiacolibyoptimizationoffivekeyfactors
AT jafarisevda enhancedproductionofinsulinlikegrowthfactoriproteininescherichiacolibyoptimizationoffivekeyfactors